InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Explore the full record of transactions filed by Hartman Curt R, Chairman & CEO. Director active across 1 companies, notably CONMED Corp. In total, 7 disclosures have been recorded. Total volume traded: €12m. The latest transaction was disclosed on 15 March 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€316,2452,500 shares@ €126.49780.025% mcap2.6% of flow
Common Stock
SEC:0001127602-22-009761:0·
€269,4312,500 shares@ €107.77250.021% mcap4.6% of flow
Common Stock
SEC:0001127602-21-025509·
€269,4312,500 shares@ €107.77250.021% mcap2.2% of flow
Common Stock
SEC:0001127602-21-025509:0·
€5m42,347 shares@ €108.86580.37% mcap79.1% of flow
Common Stock
SEC:0001127602-21-019252·
€5m42,347 shares@ €108.86580.37% mcap38.5% of flow
Common Stock
SEC:0001127602-21-019252:0·
€949,7878,030 shares@ €118.27980.076% mcap16.3% of flow
Common Stock
SEC:0001127602-21-017260·
€949,7878,030 shares@ €118.27980.076% mcap7.9% of flow
Common Stock
SEC:0001127602-21-017260:0·
7 of 7 declarations
About Hartman Curt R
Curt R. Hartman is the Chairman & CEO of CONMED Corp, a company specializing in medical devices. As a leader, he oversees the strategic operations and overall direction of the company, aiming to enhance healthcare quality through innovative solutions. His experience and commitment to operational excellence are significant assets for the organization.
